{"id":"W4415494179","doi":"10.1007/s13555-025-01562-4","title":"Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials","year":2025,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Trent University; University of British Columbia; SKiN Health; Queen's University; Probity Medical Research; University of Toronto","funders":"LEO Pharma; Bausch Health; Sanofi Genzyme; Incyte; Castle Biosciences; Dermira; Sun Pharma; Regeneron Pharmaceuticals; Helsinn; Celgene; Celltrion; Valeant Pharmaceuticals International; Sanofi; Amgen; Helsinn Therapeutics; Meiji Seika Pharma; Pfizer; Galderma; Ortho Dermatologics; Eli Lilly and Company","keywords":"Dermis; Clinical trial; Roflumilast; Plaque psoriasis; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003604442,0.0003255816,0.0008286387,0.0001307816,0.0003365215,0.00002732193,0.0001800576,0.0004359121,0.00006728068],"category_scores_gemma":[0.00008843766,0.0001966387,0.00007514082,0.0001832866,0.000323612,0.00009138967,0.00004688401,0.0002412203,0.00001557691],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002734293,"about_ca_system_score_gemma":0.0001160465,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003429462,"about_ca_topic_score_gemma":0.0004873849,"domain_scores_codex":[0.9974436,0.001046831,0.0006078593,0.0004922235,0.00003645176,0.0003731068],"domain_scores_gemma":[0.9978405,0.001502749,0.0002259644,0.0003570008,0.00004525717,0.00002848601],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.06714163,0.003431608,0.4118634,0.00003081182,0.006404309,0.0001054599,0.00397756,0.000002164264,0.004954578,0.001659994,0.007455253,0.4929732],"study_design_scores_gemma":[0.2794332,0.001503127,0.6053998,0.0002502884,0.0008141322,0.00008378567,0.0005859527,0.000009221396,0.04759293,0.001817993,0.06181068,0.0006988249],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9670809,0.0292554,0.00002582764,0.001855385,0.000456563,0.0007578988,0.0002915479,0.00004646556,0.0002300059],"genre_scores_gemma":[0.9927793,0.005493246,0.00001650545,0.0007702507,0.00003852449,0.0001251272,0.0005947182,0.00001459331,0.0001677228],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4922744,"threshold_uncertainty_score":0.8018693,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01504372083051549,"score_gpt":0.258465775379876,"score_spread":0.2434220545493605,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}